S&P 500   4,548.52 (-0.03%)
DOW   35,681.07 (+0.22%)
QQQ   375.97 (-0.34%)
AAPL   149.83 (+0.23%)
MSFT   309.45 (-0.42%)
FB   324.71 (-5.02%)
GOOGL   2,764.79 (-2.57%)
TSLA   905.67 (+1.31%)
AMZN   3,394.92 (-1.17%)
NVDA   229.55 (+1.16%)
BABA   180.98 (+2.01%)
NIO   39.82 (-0.38%)
CGC   13.63 (-2.92%)
GE   104.46 (+1.27%)
AMD   119.69 (+0.30%)
MU   68.03 (-0.89%)
T   25.64 (-0.47%)
F   16.42 (-0.79%)
ACB   7.22 (-2.04%)
DIS   170.10 (-0.72%)
PFE   42.86 (+0.00%)
BA   216.16 (+0.85%)
AMC   36.93 (-5.89%)
S&P 500   4,548.52 (-0.03%)
DOW   35,681.07 (+0.22%)
QQQ   375.97 (-0.34%)
AAPL   149.83 (+0.23%)
MSFT   309.45 (-0.42%)
FB   324.71 (-5.02%)
GOOGL   2,764.79 (-2.57%)
TSLA   905.67 (+1.31%)
AMZN   3,394.92 (-1.17%)
NVDA   229.55 (+1.16%)
BABA   180.98 (+2.01%)
NIO   39.82 (-0.38%)
CGC   13.63 (-2.92%)
GE   104.46 (+1.27%)
AMD   119.69 (+0.30%)
MU   68.03 (-0.89%)
T   25.64 (-0.47%)
F   16.42 (-0.79%)
ACB   7.22 (-2.04%)
DIS   170.10 (-0.72%)
PFE   42.86 (+0.00%)
BA   216.16 (+0.85%)
AMC   36.93 (-5.89%)
S&P 500   4,548.52 (-0.03%)
DOW   35,681.07 (+0.22%)
QQQ   375.97 (-0.34%)
AAPL   149.83 (+0.23%)
MSFT   309.45 (-0.42%)
FB   324.71 (-5.02%)
GOOGL   2,764.79 (-2.57%)
TSLA   905.67 (+1.31%)
AMZN   3,394.92 (-1.17%)
NVDA   229.55 (+1.16%)
BABA   180.98 (+2.01%)
NIO   39.82 (-0.38%)
CGC   13.63 (-2.92%)
GE   104.46 (+1.27%)
AMD   119.69 (+0.30%)
MU   68.03 (-0.89%)
T   25.64 (-0.47%)
F   16.42 (-0.79%)
ACB   7.22 (-2.04%)
DIS   170.10 (-0.72%)
PFE   42.86 (+0.00%)
BA   216.16 (+0.85%)
AMC   36.93 (-5.89%)
S&P 500   4,548.52 (-0.03%)
DOW   35,681.07 (+0.22%)
QQQ   375.97 (-0.34%)
AAPL   149.83 (+0.23%)
MSFT   309.45 (-0.42%)
FB   324.71 (-5.02%)
GOOGL   2,764.79 (-2.57%)
TSLA   905.67 (+1.31%)
AMZN   3,394.92 (-1.17%)
NVDA   229.55 (+1.16%)
BABA   180.98 (+2.01%)
NIO   39.82 (-0.38%)
CGC   13.63 (-2.92%)
GE   104.46 (+1.27%)
AMD   119.69 (+0.30%)
MU   68.03 (-0.89%)
T   25.64 (-0.47%)
F   16.42 (-0.79%)
ACB   7.22 (-2.04%)
DIS   170.10 (-0.72%)
PFE   42.86 (+0.00%)
BA   216.16 (+0.85%)
AMC   36.93 (-5.89%)
NASDAQ:HQY

HealthEquity Stock Forecast, Price & News

$67.35
+1.48 (+2.25 %)
(As of 10/22/2021 10:40 AM ET)
Add
Compare
Today's Range
$66.55
$67.49
50-Day Range
$61.14
$71.82
52-Week Range
$49.09
$93.32
Volume7,896 shs
Average Volume623,249 shs
Market Capitalization$5.62 billion
P/E Ratio6,735.00
Dividend YieldN/A
Beta1.37
30 days | 90 days | 365 days | Advanced Chart
Receive HQY News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.


HealthEquity logo

About HealthEquity

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm's offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HQY
Employees
3,020
Year Founded
N/A

Sales & Book Value

Annual Sales
$733.57 million
Cash Flow
$2.74 per share
Book Value
$16.78 per share

Profitability

Net Income
$8.83 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$5.62 billion
Next Earnings Date
12/6/2021 (Estimated)
Optionable
Optionable

MarketRank

Overall MarketRank

2.06 out of 5 stars

Medical Sector

504th out of 1,358 stocks

Business Services, Not Elsewhere Classified Industry

63rd out of 133 stocks

Analyst Opinion: 3.4Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -












HealthEquity (NASDAQ:HQY) Frequently Asked Questions

Is HealthEquity a buy right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 3 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" HealthEquity stock.
View analyst ratings for HealthEquity
or view top-rated stocks.

What stocks does MarketBeat like better than HealthEquity?

Wall Street analysts have given HealthEquity a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but HealthEquity wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is HealthEquity's next earnings date?

HealthEquity is scheduled to release its next quarterly earnings announcement on Monday, December 6th 2021.
View our earnings forecast for HealthEquity
.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) posted its quarterly earnings data on Tuesday, September, 7th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The firm had revenue of $189.10 million for the quarter, compared to analysts' expectations of $184.99 million. HealthEquity had a net margin of 0.10% and a trailing twelve-month return on equity of 5.25%. HealthEquity's revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.29 EPS.
View HealthEquity's earnings history
.

How has HealthEquity's stock price been impacted by COVID-19?

HealthEquity's stock was trading at $50.32 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HQY stock has increased by 30.9% and is now trading at $65.87.
View which stocks have been most impacted by COVID-19
.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity issued an update on its FY 2022 earnings guidance on Thursday, October, 7th. The company provided earnings per share (EPS) guidance of $1.450-$1.500 for the period, compared to the Thomson Reuters consensus estimate of $1.490. The company issued revenue guidance of $755 million-$765 million, compared to the consensus revenue estimate of $762.75 million.

What price target have analysts set for HQY?

11 brokers have issued twelve-month price objectives for HealthEquity's stock. Their forecasts range from $72.00 to $100.00. On average, they expect HealthEquity's share price to reach $85.70 in the next twelve months. This suggests a possible upside of 30.1% from the stock's current price.
View analysts' price targets for HealthEquity
or view top-rated stocks among Wall Street analysts.

Who are HealthEquity's key executives?

HealthEquity's management team includes the following people:
  • Jon Kessler, President, Chief Executive Officer & Director
  • Ted Bloomberg, Chief Operating Officer & Executive VP
  • Tyson Murdock, Chief Financial Officer & Executive Vice President
  • Becky Whitehead, EVP, Chief Technology & Information Officer
  • Jody Dietel, Senior Vice President-Compliance & Regulatory News

What is Jon Kessler's approval rating as HealthEquity's CEO?

197 employees have rated HealthEquity CEO Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among HealthEquity's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Square (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), The Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

What is HealthEquity's stock symbol?

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by a variety of retail and institutional investors. Top institutional investors include Scout Investments Inc. (0.18%), Oregon Public Employees Retirement Fund (0.03%), Louisiana State Employees Retirement System (0.03%), Pacer Advisors Inc. (0.01%), Stratos Wealth Partners LTD. (0.01%) and Harbor Investment Advisory LLC (0.00%). Company insiders that own HealthEquity stock include Ashley Dreier, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Larry L Trittschuh and William Robert Otten.
View institutional ownership trends for HealthEquity
.

Which institutional investors are selling HealthEquity stock?

HQY stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., Oregon Public Employees Retirement Fund, and Louisiana State Employees Retirement System. Company insiders that have sold HealthEquity company stock in the last year include Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Larry L Trittschuh, and William Robert Otten.
View insider buying and selling activity for HealthEquity
or view top insider-selling stocks.

Which institutional investors are buying HealthEquity stock?

HQY stock was purchased by a variety of institutional investors in the last quarter, including Stratos Wealth Partners LTD., Pacer Advisors Inc., Harbor Investment Advisory LLC, and Exchange Traded Concepts LLC.
View insider buying and selling activity for HealthEquity
or or view top insider-buying stocks.

How do I buy shares of HealthEquity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HealthEquity's stock price today?

One share of HQY stock can currently be purchased for approximately $65.87.

How much money does HealthEquity make?

HealthEquity has a market capitalization of $5.50 billion and generates $733.57 million in revenue each year. The company earns $8.83 million in net income (profit) each year or $1.22 on an earnings per share basis.

How many employees does HealthEquity have?

HealthEquity employs 3,020 workers across the globe.

What is HealthEquity's official website?

The official website for HealthEquity is www.healthequity.com.

Where are HealthEquity's headquarters?

How can I contact HealthEquity?

HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at (801) 727-1000 or via email at [email protected].


This page was last updated on 10/22/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.